JP fyi on point 4 re last chairmans blog : R
Post# of 30025
Posted On: 09/22/2014 11:32:47 AM
JP fyi on point 4
re last chairmans blog :
re last chairmans blog :
Quote:
Receive Feedback from the FDA on our proposed PD LID trial design (of note, based on a further analysis of the data we expect the trial to be significantly less than 200 patients) and finalize the trial design
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼